Research & News

Postpartum HIV Treatment Discontinuation and Maternal Outcomes

Jul 05, 2009

Though the use of highly active antiretroviral therapy (HAART) during pregnancy has significantly contributed to decreased rates of mother to child transmission of HIV, the question of whether HAART should be routinely continued in HIV-infected mothers after delivery has... Read More

CDC Releases Guidelines for Pregnant Women and Novel Influenza A (H1N1)

Jun 29, 2009

The CDC has released guidelines for pregnant women, including those who are HIV-positive, and novel influenza A (H1N1). The guidelines recommend the use of oseltamivir (Tamiflu) for pregnant women with confirmed, probable or suspected cases of novel influenza A (H1N1)... Read More

Effects of Antiretroviral Treatment Interruption During Pregnancy

Jun 21, 2009

A recent study finds that discontinuing antiretroviral treatment during either the first or third trimesters of pregnancy increases the rate of mother-to-child transmission of HIV. Citation: Galli L, Puliti D, Chiappini E, Gabiano C, Ferraris G, Mignone F, Viganò A,... Read More

Update on Progress Regarding Prevention of Mother-to-Child Transmission of HIV

Jun 11, 2009

A recent article describes the successes and challenges of preventing mother-to-child transmission of HIV. Progress in both resource-rich and resource-limited countries is examined. Citation:Paintsil E, Andiman WA. Update on successes and challenges regarding mother-to-... Read More

Lopinavir/r Safe For Use During Pregnancy

May 18, 2009

A recent study finds no difference in the prevalence of birth defects among infants prenatally exposed to lopinavir/ritonavir and infants in comparison groups. These data provide additional assurance about the safety of lopinavir/ritonavir in the treatment of pregnant HIV-... Read More

Nevirapine and Risk of Hepatotoxicity

May 18, 2009

Research shows that use of nevirapine for prophylaxis for two weeks or more increases rates of hepatotoxicity for individuals without HIV and HIV-positive pregnant women. Less hepatotoxicity was found in short course use of the drug, thus duration of therapy significantly... Read More

Disparity in Utilization of Rapid HIV Testing for Women in Labor

May 17, 2009

Study finds low compliance with rapid HIV testing for women with unknown HIV status and socioeconomic disparities in testing practices. Citation:Gaur S, Whitley-Williams P, Flash C, Jimenez E, Petrova A. Disparity in hospital utilization of rapid HIV-1 testing for women in... Read More

ART In Utero and Fetal Anomalies

May 16, 2009

A significant national study in the UK and Ireland found that HIV-positive women treated with ART during pregnancy had no increased risk of fetal anomalies regardless of the trimester in which fetal exposure occurred. Citation: Townsend CL, Willey BA, Cortina-Borja M,... Read More

Benefits of Early Initiation of Antiretroviral Therapy

Apr 19, 2009

Study finds improved survival in patients receiving early antiretroviral therapy as compared to those in the deferred therapy group. Citation: Kitahata MM, Gange SJ, Abraham AG, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J... Read More

Antiretroviral Medications During Pregnancy

Apr 19, 2009

Article summarizes recent studies examining the safety of antiretroviral medications for mother, fetus and child. Citation: Stek AM. Antiretroviral medications during pregnancy for therapy or prophylaxis. Curr HIV/AIDS Rep. 2009 May;6(2):68-76.Abstract

Pages